Simultaneous silencing of multiple apoptosis-related genes is an attractive approach to treat cancer. In this article, we present a multiple gene-targeting siRNA/drug delivery system for prostate cancer treatment with a high efficiency. Bcl-2, survivin, and androgen receptor genes involved in the cell apoptosis pathways were chosen as silencing targets with three different siRNAs. The colloidal nanocomplex delivery system (<10 nm in size) was formulated electrostatically between anionic siRNAs and a cationic drug (BZT), followed by encapsulation with the Pluronic F-68 polymer. The formulated nanocomplex system exhibited sufficient stability against nuclease-induced degradation, leading to successful intracellular delivery for the desired th...
Objective: Tumor suppressor miRNAs, miR-15a and miR-16�1, with high-specificity and oncogenic targ...
With the capability of specific silencing of target gene expression, RNA interference (RNAi) technol...
The efficiency of siRNA is limited by its low resistance against enzymatic degradation, limited perm...
Prostate cancer (PCa) accounts for a high number of deaths in males with no available curative treat...
Gene therapy is an elegant alternative to chemotherapy, with its well known severe side-effects, as ...
Prostate cancer is one of the most common cancers diagnosed in men. Whilst treatments for early-stag...
Nanocarriers have received special attention in biomedicine for the treatment of various diseases, e...
Nanocarriers have received special attention in biomedicine for the treatment of various diseases, e...
The chemistry of gold nanoparticles (AuNPs) facilitates surface modifications and thus these bioengi...
International audienceThis paper examines a perspective to use newly engineered nanomaterials as eff...
Here we describe a simple way to create a gold nanoparticle (AuNP)-based non-viral delivery system t...
Despite great progress in recent years, efficient delivery of gene therapy or chemotherapy drugs int...
Cisplatin and other DNA-damaging chemotherapeutics are widely used to treat a broad spectrum of mali...
Gene silencing using small interfering RNA (siRNA) has shown significant potential in the treatment ...
© 2022 Elsevier B.V.Combinational gene and chemo-therapy approach has been investigated for more eff...
Objective: Tumor suppressor miRNAs, miR-15a and miR-16�1, with high-specificity and oncogenic targ...
With the capability of specific silencing of target gene expression, RNA interference (RNAi) technol...
The efficiency of siRNA is limited by its low resistance against enzymatic degradation, limited perm...
Prostate cancer (PCa) accounts for a high number of deaths in males with no available curative treat...
Gene therapy is an elegant alternative to chemotherapy, with its well known severe side-effects, as ...
Prostate cancer is one of the most common cancers diagnosed in men. Whilst treatments for early-stag...
Nanocarriers have received special attention in biomedicine for the treatment of various diseases, e...
Nanocarriers have received special attention in biomedicine for the treatment of various diseases, e...
The chemistry of gold nanoparticles (AuNPs) facilitates surface modifications and thus these bioengi...
International audienceThis paper examines a perspective to use newly engineered nanomaterials as eff...
Here we describe a simple way to create a gold nanoparticle (AuNP)-based non-viral delivery system t...
Despite great progress in recent years, efficient delivery of gene therapy or chemotherapy drugs int...
Cisplatin and other DNA-damaging chemotherapeutics are widely used to treat a broad spectrum of mali...
Gene silencing using small interfering RNA (siRNA) has shown significant potential in the treatment ...
© 2022 Elsevier B.V.Combinational gene and chemo-therapy approach has been investigated for more eff...
Objective: Tumor suppressor miRNAs, miR-15a and miR-16�1, with high-specificity and oncogenic targ...
With the capability of specific silencing of target gene expression, RNA interference (RNAi) technol...
The efficiency of siRNA is limited by its low resistance against enzymatic degradation, limited perm...